Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Foresee Pharmaceuticals Enters Exclusive License Agreement with Intas Pharmaceuticals for Commercialization in the United States 2021-03-04 23:00
Yuyu Pharma Publishes History for 80th Anniversary 2021-03-03 22:00
I-Mab to Report Financial Results for the Full Year 2020 and Provide Corporate Update on March 29, 2021 2021-03-03 21:00
SciClone Pharmaceuticals Officially Listed on the Main Board of the Hong Kong Stock Exchange 2021-03-03 16:43
CMAB Biopharma Congratulates Partner Innovent Biologics on FDA Clearance of IND Application of its COVID-19 Antibody Project 2021-03-03 11:12
Cipla Gulf Expands Partnership with Alvotech for Commercialization of Biosimilars in Australia and New Zealand 2021-03-02 22:05
Merck and GPHL Collaborate on Business Innovation and Development in the Greater Bay Area 2021-03-02 18:12
Oscotec and Beactica Therapeutics announce license and collaboration agreement to develop new cancer drug 2021-03-02 15:21
CMAB Biopharma Congratulates QureBio on FDA Clearance of IND Application for Claudin18.2/PD-L1 Bispecific Antibody 2021-03-02 13:43
INOVIO Announces Positive Results from REVEAL 1, a Phase 3 Pivotal Trial Evaluating VGX-3100, its DNA-based HPV Immunotherapy for the Treatment of High-grade Precancerous Cervical Dysplasia Caused by HPV-16 and/or HPV-18 2021-03-02 05:05
China Biologic Announces Shareholders' Approval of Merger Agreement 2021-03-01 21:00
Everest Medicines Announces Selection as a Constituent of Certain Indexes of Hang Seng Indexes Company Limited 2021-03-01 12:36
Sciwind's Investigational New Drug Approved for NASH Trial 2021-03-01 09:00
Innovent Announces First Patient Outside China Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody 2021-03-01 08:23
Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Indexes Including the Hang Seng Composite Index 2021-03-01 08:00
Sirtex Medical receives positive recommendation from National Institute for Health and Care Excellence (NICE) for selective internal radiation therapy (SIRT) using SIR-Spheres® 2021-02-26 23:37
LISCure Biosciences Successfully Raises $21 million in Series B Funding 2021-02-26 22:00
Alterity to present at the 7th International Congress of Multiple System Atrophy 2021-02-26 20:45
Debiopharm And Genome & Company Join Forces To Create New Highly Specific Therapies For Cancer Patients 2021-02-26 19:14
Tigermed Supported and Delivered Clinical Study of CanSino COVID-19 Vaccine as Clinical Contract Research Organization 2021-02-26 16:36
1 256 257 258 259 260 412